Skip to main content

Advertisement

Table 1 Patients’ Characteristics

From: Selective oestrogen receptor antagonists inhibit oesophageal cancer cell proliferation in vitro

Patients recruited 34
Median age (years) 65 (range, 30–79)
One-year disease-specific survival 73.5%
Gender Male 28 (83%)
Female 6 (17%)
Histology Adenocarcinoma 28 (76%)
Squamous cell carcinoma 6 (24%)
Tumour depth (T-stage) T1 8 (24%)
T2 3 (9%)
T3 23 (67%)
Nodal involvement No (N0) 15 (44%)
Yes (N1) 19 (56%)
Tumour differentiation Moderate 25 (74%)
Poor 9 (26%)
Vascular invasion No 21(62%)
Yes 13 (38%)
Barrett’s Metaplasia No 13 (46%)
Yes 15 (54%)
Circumferential resection margin Not involved 23 (68%)
Involved 11 (32%)
Preoperative chemotherapy No 9 (26%)
Yes 25 (74%)